Accreditation Information April 2024

Accreditation & Disclosures
36th Clinical Applications for Age Management Medicine
April 10 – 14, 2024 | Miami, Florida


This conference provides Physicians and Healthcare Providers evidence-based research and clinical protocols on new procedures, methods, and topics in Age Management Medicine that will increase competency, knowledge and provide treatment tools that improve patient outcomes and patient satisfaction.


  • Recognize the science and current case studies behind the use of Estradiol, Progesterone and Testosterone for women.
  • Recognize hormone testing methodologies and hormone delivery systems and how to apply those in a clinical setting to improve patient outcomes.
  • Recognize the science and current case studies behind the use of testosterone in men.
  • Recognize and understand how to manage the complications of hormone therapy.
  • Review the neurobiology and science of Traumatic Brain Injury.
  • Apply proper diagnostic methods to identify patients with TBI.
  • Use appropriate individualized treatment strategies to treat patients for improved patient outcomes.
  • Educate and inform physicians on the current state of FDA regulations as they pertain to Peptides, Hormones and Dietary Supplements.
  • Recognize the role that Glycans play in the aging process and apply this fundamental knowledge to provide a precise approach in preventative and personalized healthcare.
  • Identify clinical protocols developed using Plasma Exchange to reduce toxin levels and reverse biomarkers of aging.
  • Describe new evidence-based strategies for a multi targeted approach to the treatment of cancer.
  • Recognize diagnostic tools that can help to distinguish types of dementia and contributing causes of dementia.
  • Recognize the issues and paradox in treatment strategies for weight loss such as mindfulness, diet, hormone imbalance, and pharmaceutical interventions.
  • Recognize how Testosterone Therapy can result in iron overload.
  • Apply evidence based diagnostic and clinical treatment protocols during TRT to manage the implications of iron overload.
  • Recognize the ways in which Molds and Mycotoxins impact the brain and gut.
  • Apply evidence-based treatment protocols to reduce or eliminate Molds and Mycotoxins to improve patient outcomes
  • Recognize how gut health can impact overall health, particularly inflammatory diseases such as obesity and inflammatory bowel disease.
  • Apply new evidence-based treatment strategies for gut health
  • Gain a comprehensive understanding of the underlying biological mechanisms through which specific nutritional interventions may modulate neuroinflammation and support neuroprotection.
  • Explore strategies for integrating targeted nutritional interventions into current concussion management protocols and prevention strategies, with a focus on evidence-based approaches and patient-centered care.
  • Recognize the pathology of Covid and Covid Vaccinations on aging.
  • Apply clinical interventions to mitigate or reverse aging aspects of s-spike protein.
  • Recognize the most current information and studies available on Lyme Disease.
  • Recognize the best and most appropriate laboratory tests to facilitate diagnosis.
  • Recognize the most effective clinical treatment options.


This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Medical Academy and the Age Management Medicine Group (AMMG). Medical Academy is accredited by the ACCME to provide continuing medical education for physicians.


Medical Academy designates this live activity for a maximum of 20.25 AMA PRA Category 1 Credit™. Physicians should claim only credit commensurate with the extent of their participation in the activity. 


All conflicts of interest of any individual(s) in a position to control the content of this CME activity will be identified and resolved prior to this educational activity being provided. Disclosure about provider and faculty relationships, or the lack thereof, will be provided to learners.


  • Florence Comite, M.D
  • Elliot Dinetz, M.D., ABFM, ABAARM
  • Mark Gordon, M.D.
  • Rob Kominiarek, D.O. FACOFP
  • Edwin Lee, M.D.
  • Luis Martinez, M.D.
  • Cesar M. Pellerano, M.D.
  • John J. Rush, M.D., FACEP, MBA, MHA
  • George Shapiro, M.D.


Gregory R. Fillmore, Director of Education, AMMG


None of the following faculty, planners and reviewers for this educational activity have relevant financial relationships to disclose during the last 24 months with ineligible companies who’s primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patient.

Andrew Campbell, M.D.
Mizyl Damayo, M.D.
Derrick DeSilva, Jr., M.D.
Rudolph Eberwein, M.D.
Sabine Hazan, M.D.
Luis Martinez, M.D.
Beatriz Olson, M.D.
Kathryn Retzler, N.D.
Yusuf J.P. Saleeby, M.D.
Paul Savage, M.D.
Maryelaine Sotos, D.O.
Paul Werner, Esq

The following speakers, planners and reviewers have indicated relevant financial relationships with the following commercial interests:

  • William Clearfield, D.O. declares the following interests: Author of Articles, Resveratrol Partners
  • Mitchell Ghen, D.O., Ph.D. declares the following interests” CMO of Hue Light
  • Mark Gordon, M.D. declares the following interests: Owner, Millennium Health Centers
  • Sharon Hausman-Cohen, M.D., FAAFP, ABIHM declares the following interests: CMO & Ownership Interest,  IntellxxDNA
  • Michael Lewis, M.D., declares that the following interests: Advisor for Nordic Naturals and Natural Stacks

All of the relevant financial relationships listed above have been mitigated by the Medical Academy and the Age Management Medicine Group (AMMG).

Educational Support:

AMMG received no educational support in the form of Grants for this educational course.